GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » PB Ratio

CanadaBis Capital (TSXV:CANB) PB Ratio : 1.53 (As of May. 17, 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-17), CanadaBis Capital's share price is C$0.09. CanadaBis Capital's Book Value per Share for the quarter that ended in Jan. 2024 was C$0.06. Hence, CanadaBis Capital's PB Ratio of today is 1.53.

The historical rank and industry rank for CanadaBis Capital's PB Ratio or its related term are showing as below:

TSXV:CANB' s PB Ratio Range Over the Past 10 Years
Min: 1.19   Med: 5.1   Max: 10
Current: 1.69

During the past 8 years, CanadaBis Capital's highest PB Ratio was 10.00. The lowest was 1.19. And the median was 5.10.

TSXV:CANB's PB Ratio is ranked better than
59.85% of 954 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs TSXV:CANB: 1.69

During the past 12 months, CanadaBis Capital's average Book Value Per Share Growth Rate was 78.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 27.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -0.80% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of CanadaBis Capital was 27.70% per year. The lowest was -31.20% per year. And the median was -9.90% per year.

Back to Basics: PB Ratio


CanadaBis Capital PB Ratio Historical Data

The historical data trend for CanadaBis Capital's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital PB Ratio Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
PB Ratio
Get a 7-Day Free Trial 13.08 8.00 10.00 1.84 5.58

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.03 6.19 5.58 4.05 3.90

Competitive Comparison of CanadaBis Capital's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's PB Ratio distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's PB Ratio falls into.



CanadaBis Capital PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

CanadaBis Capital's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jan. 2024)
=0.09/0.059
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


CanadaBis Capital  (TSXV:CANB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


CanadaBis Capital PB Ratio Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus

Can B Corp.'s Pure Health Products Awarded NSF's GMP Certification

By GuruFocusNews GuruFocusNews 12-30-2021